Abstract
Japanese encephalitis virus (JEV) is a mosquitoborne virus endemic to China and Southeast Asia that causes severe encephalitis in <1% of infected persons. Transmission of JEV via blood transfusion has not been reported. We report transmission of JEV via blood donation products from an asymptomatic viremic donor to 2 immunocompromised recipients. One recipient on high-dose immunosuppressive drugs received JEV-positive packed red blood cells after a double lung transplant; severe encephalitis and a poor clinical outcome resulted. JEV RNA was detected in serum, cere-brospinal fluid, and bronchoalveolar lavage fluid specimens. The second recipient had leukemia and received platelets after undergoing chemotherapy. This patient was asymptomatic; JEV infection was confirmed in this person by IgM sero-conversion. This study illustrates that, consistent with other pathogenic flaviviruses, JEV can be transmitted via blood products. Targeted donor screening and pathogen reduction technologies could be used to prevent transfusion-transmitted JEV infection in highly JEV-endemic areas.
Original language | English |
---|---|
Pages (from-to) | 49-57 |
Number of pages | 9 |
Journal | Emerging Infectious Diseases |
Volume | 24 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2018 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2017, Centers for Disease Control and Prevention (CDC). All rights reserved.
ASJC Scopus Subject Areas
- Epidemiology
- Microbiology (medical)
- Infectious Diseases